spesolimab

💊Medication

Generic name

Spesolimab-Sbzo

Brand names

Spevigo

Drug class

Interleukin-36 Receptor Antagonist, Interleukin-36 Receptor Antagonists

Route

Intravenous

Type

Human Prescription Drug

Manufacturer

Boehringer Ingelheim Pharmaceuticals, Inc.

Indications: 1 INDICATIONS AND USAGE SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg. SPEVIGO is an interleukin-36 receptor antagonist indicated for the treatment of generalized pustular psori… (per FDA label)

• PHASE3RECRUITING
  A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumBoehringer Ingelheim · NCT06624670
• PHASE2COMPLETED
  A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular PsoriasisBoehringer Ingelheim · NCT04399837
• PHASE2TERMINATED
  A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel ObstructionBoehringer Ingelheim · NCT05013385
• PHASE2COMPLETED
  A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis SuppurativaBoehringer Ingelheim · NCT04762277
• PHASE3COMPLETED
  An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsBoehringer Ingelheim · NCT05239039
• PHASE2/PHASE3COMPLETED
  BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative ColitisBoehringer Ingelheim · NCT03482635

via ClinicalTrials.gov

Wikidata facts

Instance of

medication

Subclass of

monoclonal antibody

via Wikidata · CC0